SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-011474
Filing Date
2018-08-20
Accepted
2018-08-20 17:30:50
Documents
99
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_icageninc.htm 10-Q 563006
2 CERTIFICATION f10q0618ex31-1_icagen.htm EX-31.1 11486
3 CERTIFICATION f10q0618ex31-2_icagen.htm EX-31.2 10760
4 CERTIFICATION f10q0618ex32-1_icagen.htm EX-32.1 3838
5 CERTIFICATION f10q0618ex32-2_icagen.htm EX-32.2 3770
  Complete submission text file 0001213900-18-011474.txt   4853678

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE icfn-20180630.xml EX-101.INS 928299
7 XBRL SCHEMA FILE icfn-20180630.xsd EX-101.SCH 69237
8 XBRL CALCULATION FILE icfn-20180630_cal.xml EX-101.CAL 50491
9 XBRL DEFINITION FILE icfn-20180630_def.xml EX-101.DEF 203353
10 XBRL LABEL FILE icfn-20180630_lab.xml EX-101.LAB 514293
11 XBRL PRESENTATION FILE icfn-20180630_pre.xml EX-101.PRE 364836
Mailing Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703
Business Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703 919-941-5206
Icagen, Inc. (Filer) CIK: 0001518520 (see all company filings)

IRS No.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54748 | Film No.: 181029022
SIC: 8731 Services-Commercial Physical & Biological Research